Swedish Orphan Biovitrum AB (publ) (BIOVF)

BIOVF Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,919	9,959	9,119	6,204	6,120	5,964
Market Cap Growth	0.01%	9.22%	46.98%	1.37%	2.62%	22.62%
Enterprise Value	12,156	11,522	11,146	7,153	7,393	7,565
Last Close Price	33.30	27.66	26.25	21.15	20.39	19.55
PE Ratio	23.75	28.37	38.07	24.52	20.66	15.10
PS Ratio	3.85	4.24	4.14	3.44	3.56	3.21
PB Ratio	2.66	2.74	2.71	2.44	2.38	2.42
P/FCF Ratio	16.01	15.27	25.50	14.36	10.21	10.03
P/OCF Ratio	15.86	14.92	20.52	14.13	10.12	9.94
EV/Sales Ratio	4.29	4.90	5.07	3.97	4.31	4.07
EV/EBITDA Ratio	11.56	13.74	14.87	11.31	11.93	9.83
EV/EBIT Ratio	18.03	21.90	24.09	16.50	17.62	13.92
EV/FCF Ratio	17.83	17.67	31.16	16.56	12.33	12.72
Debt / Equity Ratio	0.33	0.42	0.61	0.34	0.47	0.72
Debt / EBITDA Ratio	1.28	1.78	2.67	1.36	1.91	2.27
Debt / FCF Ratio	1.98	2.32	5.70	2.02	2.01	2.98
Asset Turnover	0.38	0.35	0.35	0.37	0.32	0.33
Inventory Turnover	1.46	1.42	1.38	1.31	1.08	1.34
Quick Ratio	0.66	0.68	0.42	0.51	0.59	0.47
Current Ratio	1.00	1.05	0.64	0.76	1.00	0.78
Return on Equity (ROE)	11.57%	10.46%	7.98%	10.61%	12.34%	17.48%
Return on Assets (ROA)	5.65%	4.87%	4.60%	5.58%	4.89%	5.94%
Return on Capital (ROIC)	7.61%	6.54%	6.46%	8.10%	6.88%	8.17%
Return on Capital Employed (ROCE)	11.30%	9.30%	8.50%	12.00%	9.50%	11.80%
Earnings Yield	4.21%	3.52%	2.63%	4.08%	4.84%	6.63%
FCF Yield	6.24%	6.55%	3.92%	6.96%	9.80%	9.97%
Buyback Yield / Dilution	-1.64%	-6.01%	-9.22%	-0.56%	0.28%	-1.06%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.